Trevi Therapeutics
TRVI
#4836
Rank
A$2.89 B
Marketcap
A$20.27
Share price
-1.49%
Change (1 day)
19.18%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2026 (TTM): -A$81.53 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$68.02 Million, an increase over its 2024 earnings that were of -A$71.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$81.53 Million19.87%
2025 -A$68.02 Million-5.42%
2024 -A$71.92 Million67%
2023 -A$43.07 Million2.43%
2022 -A$42.05 Million-14.45%
2021 -A$49.15 Million1.36%
2020 -A$48.49 Million23.64%
2019 -A$39.22 Million27.54%
2018 -A$30.75 Million